TSHA
Taysha Gene Therapies, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Taysha Gene Therapies (TSHA) Stock: Buy, Sell, or Hold?
$4.28
+0.00 (+0.12%)
â˛
5d:
-1.83%
30d:
+19.55%
90d:
-28.55%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
46/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$3.86 â $4.39
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-9.3x
Next 12M consensus est.
Wall Street Target
$13.00
+203.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.92 / $4.53
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: TSHA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When TSHA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TSHA is currently trading at $4.28, which is considered slightly high relative to its 30-day fair value range of $3.86 to $4.39.
Technical Outlook: Technically, TSHA is in a strong downtrend. Immediate support is located at $3.92, while resistance sits at $4.53.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+203.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TSHA is in a strong downtrend. Immediate support is located at $3.92, while resistance sits at $4.53.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.00 (+203.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.86 -
$4.39
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.8%
Trading Range & Key Levels
30-Day Trading Range
$3.86 -
$4.39
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$3.92
Resistance Level
$4.53
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 203.7% below Wall St target ($13.00)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-9.25
Wall Street Target
$13.00
(+203.7%)
Revenue Growth (YoY)
171.3%
Share TSHA Analysis
Share this live TSHA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TSHA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment prevails on StockTwits for $TSHA with no recent news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:51 AM ET
Data refreshes hourly during market hours. Next update: 3:51 AM
Data refreshes hourly during market hours. Next update: 3:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TSHA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TSHA Research Pages
